Skip to main content

Emphysema clinical trials at UCSD
3 in progress, 2 open to new patients

  • Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)

    open to eligible people ages 45-80

    Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.

    San Diego, California and other locations

  • Losartan Effects on Emphysema Progression

    open to eligible people ages 40 years and up

    A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo

    San Diego, California and other locations

  • Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function

    Sorry, in progress, not accepting new patients

    EMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with emphysema. Patients appropriate for the EMPROVE study are those who are currently on medical treatment but still symptomatic. EMPROVE also accepts α-1 antitrypsin deficiency patients.

    San Diego, California and other locations